Aesthetic Medicine“Ozempic face” and the GLP-1 boom are changing the face of beautyMaroefah Smith 18 hours
Noncommunicable diseasesSpringbok, Bafana Bafana stars tackle obesity in new Novo Nordisk campaign15 Sep 2026
Women's Health#WomensHealthMatters: Discovery Health sponsors women’s health conferenceMaroefah Smith 11 Sep 2026
Mental healthOzempic, Wegovy and Mounjaro could “fuel the fire” of mental illness, warns psychiatrist7 Sep 2026
Ethics & MedicolegalNovo Nordisk v iDexis: What’s in a name (or, in this case, a compounded medicine)?24 Jul 2026
PharmaceuticalsAfter Novo Nordisk legal action, Pretoria pharmacy’s Ozempic copies recalledNqobile Dludla 13 Jul 2026
IP LawLessons from Novo Nordisk’s Ozempic patent loss in CanadaSara-Jane Pluke and Emmanuel Okeke 7 Jul 2026
PharmaceuticalsPrice war in weight-loss drugs heats up as Novo Nordisk reduces Wegovy pricesNqobile Dludla 26 Mar 2026
PharmaceuticalsAspen Pharmacare to capitalise on GLP-1 demand in sub-Saharan AfricaNqobile Dludla 4 Mar 2026
TourismSun’s out, buns out: Is it time for the hospitality sector to brace for the Ozempic effect?Rachel Irvine 17 Dec 2025
PharmaceuticalsOn-the-go solutions drive the future of weight managementIssued by Insight Survey 6 Oct 2025
PharmaceuticalsWeight loss drug semaglutide shown to be safe and potentially more effective at higher dose – new findingsMartin Whyte 18 Sep 2025
Noncommunicable diseasesExperts call for mandatory warning labels to combat South Africa's childhood obesity8 Sep 2025
PharmaceuticalsDanish weight-loss drug Wegovy debuts in South Africa, challenging Eli LillyNqobile Dludla and Siyanda Mthethwa 14 Aug 2025
Hospital GroupsNovo Nordisk's parent invests in India's Manipal hospital chainAnna Ringstrom and Rishika Sadam 7 Feb 2024
PharmaceuticalsEU probes Novo Nordisk drugs after reports of suicidal thoughtsBhanvi Satija 10 Jul 2023
PharmaceuticalsBrand Finance Healthcare 2023 Report reveals resilience amidst post-pandemic slump7 Jul 2023